TNFSF10 and neoplasm: It has been shown that sensitivity to TRAIL is anchorage-dependent [38], [39] suggesting that anchorage-independent circulating tumor cells may have altered response to TRAIL in comparison to anchorage-dependent cells from the primary tumor.